Evidence map›Paper›PMID 35785515›Full record

ArticleLiver international : official journal of the International Association for the Study of the Liver2022

Hepatic abnormalities in youth with Turner syndrome.

Isani Singh, Gillian Noel, Jennifer M Barker, Kathryn C Chatfield, Anna Furniss, Amber D Khanna, Natalie J Nokoff, Sonali Patel, Laura Pyle, Leena Nahata and 5 more

Open access · greenAbstract read
In one paragraph

Article in Liver international : official journal of the International Association for the Study of the Liver, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 10 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
10citing papers in PubMed, 1 pooled it
3.0field-weighted citation impact, top 8% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

10 citing papers in PubMed, 1 synthesis or guideline pooled it, 18 citations in OpenAlex.

  1. Guideline
  2. Article
  3. Approach to the Patient With Turner Syndrome.The Journal of clinical endocrinology and metabolism · 2025
    Review
  4. Article
  5. Sex Hormones and Metabolic Dysfunction-Associated Steatotic Liver Disease.International journal of molecular sciences · 2025
    Review
  6. Article
  7. Article
  8. Article
  9. Review
  10. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

15 authors at 10 institutions in 1 country.

Isani SinghHarvard University, Cambridge, Massachusetts, USA.ORCID 0000-0001-7954-4964
Gillian NoelDepartment of Pediatrics, Duke University, Durham, USA.
Jennifer M BarkereXtraOrdinarY Kids Clinic and Research Program, Children's Hospital of Colorado, Aurora, Colorado, USA.
Kathryn C ChatfieldeXtraOrdinarY Kids Clinic and Research Program, Children's Hospital of Colorado, Aurora, Colorado, USA.
Anna FurnissAdult and Child Consortium for Health Outcomes Research and Delivery Science (ACCORD), University of Colorado, Aurora, Colorado, USA.
Amber D KhannaDepartments of Medicine and Pediatrics, Division of Cardiology, University of Colorado School of Medicine, Aurora, Colorado, USA.
Natalie J NokoffDepartment of Pediatrics, University of Colorado School of Medicine, Aurora, Colorado, USA.
Sonali PateleXtraOrdinarY Kids Clinic and Research Program, Children's Hospital of Colorado, Aurora, Colorado, USA.
Laura PyleeXtraOrdinarY Kids Clinic and Research Program, Children's Hospital of Colorado, Aurora, Colorado, USA.
Leena NahataCenter for Biobehavioral Health, Abigail Wexner Research Institute, Columbus, Ohio, USA.
Francis S ColeEdward Mallinckrodt Department of Pediatrics, Washington University School of Medicine, and St. Louis Children's Hospital, St. Louis, Missouri, USA.
Chijioke IkomiDepartment of Pediatrics, Division of Weight Management, Nemours Children's Health, Jacksonville, Florida, USA.
Vaneeta BambaDepartment of Pediatrics, Division of Endocrinology, Children's Hospital of Philadelphia, Philadelphia, Pennsylvania, USA.
Patricia Y FechnerDepartment of Pediatrics, Division of Endocrinology, Seattle Children's, University of Washington, Seattle, Washington, USA.
Shanlee M DaviseXtraOrdinarY Kids Clinic and Research Program, Children's Hospital of Colorado, Aurora, Colorado, USA.
Children's Hospital Colorado · USUniversity of Colorado Denver · USChildren's Hospital of Philadelphia · USDuke University · USHarvard University Press · USNationwide Children's Hospital · USNemours Children's Health System · USOutcomes Research Consortium · USSeattle Children's Hospital · USSt. Louis Children's Hospital · US

Funding

TESTO: Testosterone Effects on Short-Term Outcomes in Infants with XXYK23HD092588 · NICHD · UNIVERSITY OF COLORADO DENVER · PI DAVIS, SHANLEE · 2017 to 2021
$826k
Population Health in Pediatric Sex Chromosome AneuploidiesR03HD102773 · NICHD · UNIVERSITY OF COLORADO DENVER · PI DAVIS, SHANLEE · 2020 to 2021
$156k
NICHD NIH HHS K23 HD092588NICHD NIH HHS R03 HD102773
6 · The paper itself

Abstract

BACKGROUND &

aimsLiver disease in children with Turner Syndrome (TS) is poorly understood relative to associated growth, cardiac and reproductive complications. This study sought to better characterize hepatic abnormalities in a large national cohort of youth with TS.

methodsUsing electronic health record data from PEDSnet institutions, 2145 females with TS were matched to 8580 females without TS on eight demographic variables. Outcomes included liver enzymes (AST and ALT) stratified as normal, 1-2 times above the upper limit of normal (ULN), 2-3 times ULN and >3 times ULN, as well as specific liver disease diagnoses.

resultsFifty-eight percent of youth with TS had elevated liver enzymes. Patients with TS had higher odds of enzymes 1-2 times ULN (OR: 1.7, 95% CI: 1.4-1.9), 2-3 times ULN (OR: 2.7, 95% CI: 1.7-3.3) and >3 times ULN (OR: 1.7, 95% CI: 1.3-2.2). They also had higher odds of any liver diagnosis (OR: 2.4, 95% CI: 1.7-3.3), fatty liver disease (OR: 1.9, 95% CI: 1.1-3.2), hepatitis (OR: 3.7, 95% CI: 1.9-7.1), cirrhosis/fibrosis (OR: 5.8, 95% CI: 1.3-25.0) and liver tumour/malignancy (OR: 4.8, 95% CI: 1.4-17.0). In a multinomial model, age, BMI and presence of cardiovascular disease or diabetes significantly increased the odds of elevated liver enzymes in girls with TS.

conclusionsYouth with TS have higher odds for elevated liver enzymes and clinically significant liver disease compared with matched controls. These results emphasize the need for clinical screening and additional research into the aetiology and treatment of liver disease in TS. LAY SUMMARY: Turner Syndrome, a chromosomal condition in which females are missing the second sex chromosome, is often associated with short stature, infertility and cardiac complications. Liver abnormalities are less well described in the literature. In this study, nearly 60% of youth with TS have elevated liver enzymes. Furthermore, patients with TS had a diagnosis of liver disease more often than patients without TS. Our results support the importance of early and consistent liver function screening and of additional research to define mechanisms that disrupt liver function in paediatric TS females.

Indexed as

Liver DiseasesTurner SyndromeAdolescentChildCohort StudiesFemaleHumansLiver Cirrhosisfatty liver diseasehormone replacement therapymosaicismPEDSnettransaminasesTurner syndrome

Identifiers

PMID35785515
PMCPMC9798872
OpenAlexW4283800249

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.